THE PROFILE OF URINE CULTURE IN PEDIATRIC PATIENTS WITH UPPER URINARY TRACT DILATATION AT DR. SOETOMO GENERAL HOSPITAL FROM 2020-2023.
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: To describe the bacteriologic profile and antimicrobial-susceptibility patterns of urine cultures from pediatric UUTD patients treated at Dr Soetomo General Hospital, Indonesia, between 2020 and 2023. Material & Methods: This retrospective descriptive study reviewed medical records of 154 inpatients aged 0–17 years with confirmed UUTD. Demographic data, cultured species, and antibiotic susceptibilities were extracted and reported as frequencies. Results: From 154 bacterial isolates, Gram-negative bacteria dominated (78.6%) compared to Gram-positive (21.4%). The most frequent species were Escherichia coli (31.8%), Pseudomonas aeruginosa (16.9%), and Klebsiella pneumoniae (12.3%). Antibiotics with the highest sensitivity against major uropathogens were amikacin (83.7%), piperacillin-tazobactam (77.6%), and meropenem (81.6%). In contrast, gentamicin and nitrofurantoin demonstrated lower sensitivities, 61.2% and 71.4%, respectively. Severe hydronephrosis occurred in 52.6% of cases and was associated with more resistant bacterial isolates. Conclusion: Urinary tract infections in pediatric UUTD patients at Dr. Soetomo General Hospital are predominantly caused by Escherichia coli, with the highest antibiotic sensitivities observed for amikacin, meropenem, and piperacillin-tazobactam. Gentamicin and nitrofurantoin should be administered based on culture results, especially for uncomplicated cystitis. Regular antibiotic resistance surveillance is essential to ensure effective empirical treatment. Keywords: Urine Culture, hydronephrosis, pediatrics, antibiotic, Escherichia coli.
##plugins.themes.bootstrap3.article.details##
Urine Culture, Hydronephrosis, Pediatrics, Escherichia coli., antibiotic
Nulens K, Lorenzo AJ, Dos Santos J, Ellul K, Rickard M. Fetal urinary-tract dilation: What to tell the parents. PrenatDiagn. 2024;44(2):148–57.
Mure PY, Mouriquand P. Upper urinary-tract dilatation: Prenatal diagnosis, management and o u t c o m e . S e m i n F e t a l N e o n a t a l M e d . 2008;13(3):152–63.
Vivier PH, Augdal TA, Avni FE, et al. Standardization of pediatric uroradiological terms: a multidisciplinary European Glossary. Pediatric Radiology. 2018; 48: 291-303.
Melo FF, Vieira AG, Braga LH, Pippi Salle JL, Macedo A. Evaluation of urinary-tract-dilation classification for long-term outcome prediction in isolated antenatal hydronephrosis: Cohort study. J Urol. 2021;206(4):1138–46.
Wu TH, Huang FL, Lin TM, Liu YH, Dai CP, Yang YL, Shao IH, Chiu NC. Treatment of recurrent complicated urinary-tract infections in children with vesicoureteral reflux. J Microbiol Immunol Infect. 2016;49(5):717–22.
Falco M, Marchini M, Caruso MI, Bianchi M, D'Amico G. Early detection of congenital anomalies of the kidney and urinary tract in neonates: Importance of systematic screening. Pediatr Nephrol. 2021;36(8):2309–18.
Matto M, Malhotra S, Sharma A, Singh R. Transition from acute to chronic urinary-tract infection in school-aged children: A prospective cohort study. J Pediatr Urol. 2021;17(5):625–33.
Lu J, Zhang Y, Shi Q, Liu L, Wang X, Yang Z. Clinical and microbial etiology characteristics in pediatric urinary-tract infection. Front Pediatr.
;10:844797.
Marsh MC, Harper MB, Gauthier M, et al. Urinary tract infections in children. Pediatr Rev. 2024;45(5):260–270. doi:10.1542/pir.2023-006017.
Priyadarshini A, Saxena R, Patel P, Gandhi S, Patel
H. Antimicrobial-resistance pattern and uropathogen distribution of pediatric urinary-tract infection in Vadodara. Afr J Biomed Res. 2024;27(3 Suppl):5835–40.
Sandia DAD, Wicaksana F, Rahmawati S, Fitriani D, Setiawan J. Pola bakteri, sensitivitas dan penggunaanantibiotik pada infeksisalurankemih. Borneo J Pharmascientech. 2024;8(1):41–55.
Naseri M, Rahmani B, Samadi N, Azadbakht M. Urinary-tract infections with non-Escherichia coli pathogens in children: An observational study. Nephro-Urol Mon. 2020;12(4):e107856.
Forster CS, Stock JA, Roth CC, et al. Uropathogens and pyuria in children with neurogenic bladders. P e d i a t r i c s . 2 0 1 8 ; 1 4 1 ( 5 ) : e 2 0 1 7 3 0 0 6 . doi:10.1542/peds.2017-3006.
Zhang Xi, Li Yang, Tao Yunzhen, Ding Yu, Shao Xuejun, Li Wei. Epidemiology and Drug Resistance of Neonatal Bloodstream Infection Pathogens in East China Children's Medical Center From 2016 to 2020. Front. Microbiol. 2022; 13: 1-11.
American Academy of Pediatrics (AAP). Reaffirmation of clinical practice guideline: Urinary tract infection—Diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2016;138(6):e20163026.
Radmayr C, Dogan HS, Hoebeke P, Kocvara R, Nijman RJM, Silay MS, Stein R, Tekgül S, Thorup J. EAU/ESPU Guidelines on Paediatric Urology. Arnhem: European Association of Urology Guidelines Office; 2024.
Daniel M, Szymanik-Grzelak H, Sierdziński J, Podsiadły E, Kowalewska-Młot M, Pańczyk- Tomaszewska M. Epidemiology and risk factors of UTIs in children—A single-center observation. J Pers Med. 2023;13(1):138.
Mahony M, McMullan B, Brown J, Kennedy SE. Multidrug-resistant organisms in urinary tract infections in children. Pediatr Nephrol. 2020;35(9):1563–73.
Esposito S, Biasucci G, Pasini A, Predieri B, Vergine G, Crisafi A, et al. Antibiotic resistance in paediatric febrile urinary tract infections. J Glob Antimicrob Resist. 2022;29:499–506.